Johnson & Johnson COVID-19 Vaccine Update

GVHC Pauses Johnson and johnson covid-19 vaccine distribution

April 13th, 2021 – Due to recent guidance from the CDC and the FDA GVHC will be pausing the distribution of the Johnson and Johnson COVID-19 Vaccine.

As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the US. The CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J& J vaccine.

Right now, these adverse events appear to be extremely rare. Patient safety is our top priority at Golden Valley Health Centers which is why we are pausing any further J& J vaccinations for now.  GVHC will continue to offer both the Moderna and Pfizer vaccine at many of our locations.

If you have received the Johnson & Johnson vaccine and have not had any side effects associated with blood clots, officials say the risk of having a reaction is unlikely.

Common temporary reactions after receiving the COVID-19 vaccine include sore arm, headache, tiredness, and fever. Some people experience lightheadedness and nausea.

The CDC recommends the following measures to prevent adverse effects:

  • Staying hydrated and having a snack before the appointment
  • Taking slow, deep breaths and focusing on something relaxing before getting the vaccine
  • Sitting or lying down after being vaccinated

People who have received the J& J vaccine and develop severe headaches, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact us by calling or texting 1-866-682-4842 to schedule an appointment with their primary care provider.

es_MXSpanish
Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.